Kurrent (formerly Event Store) | $12,000,000 | (Dec 19, 2024)
Jome | $9,800,000 | (Dec 19, 2024)
Scripta Insights | $17,000,000 | (Dec 19, 2024)
Certified by Founder
Lodge
Angitia Biopharmaceuticals
start up
United States
- Woodland Hills, CA
- 12/12/2024
- Series C
- $120,000,000
Angitia is a clinical-stage biotechnology company focused on discovering and developing breakthrough therapeutics that address the key unmet medical needs of serious musculoskeletal diseases. With the team’s experience and scientific expertise in new drug development, Angitia is dedicated to bringing innovative therapeutics to help patients in need.
- Industry Biotechnology Research
- Website https://www.angitiabio.com/
- LinkedIn https://www.linkedin.com/company/angitia-biopharmaceuticals/
Related People
Hua Zhu (David) KeFounder
United States -
Greater Los Angeles, California
Discovery and translational research professional, specifically in bone and renal diseases.
Seekho | $8,000,000 | (Dec 19, 2024)
Fitsol | $1,000,000 | (Dec 19, 2024)
Mantis Robotics | $5,000,000 | (Dec 19, 2024)
ZENRG Services | Undisclosed Amount | (Dec 19, 2024)
Hamming AI | $3,800,000 | (Dec 19, 2024)
Stand | $30,000,000 | (Dec 18, 2024)
Anatomy Financial | $19,000,000 | (Dec 18, 2024)
Slip Robotics | $28,000,000 | (Dec 18, 2024)
Twill | $1,400,000 | (Dec 18, 2024)